Back to top
more

Cytosorbents (CTSO)

(Delayed Data from NSDQ)

$0.89 USD

0.89
14,469

0.00 (0.24%)

Updated Jun 7, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (89 out of 248)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

Cytosorbents Corporation [CTSO]

Reports for Purchase

Showing records 161 - 180 ( 184 total )

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 161

04/01/2015

Company Report

Pages: 7

Reports 4Q14 Results; Maintaining BUY Rating and $18.75 PT

Provider: Merriman Curhan Ford & Co.

Analyst: D SILVA A

Price: 25.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 162

03/22/2015

Company Report

Pages: 1

Price:

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 163

02/03/2015

Company Report

Pages: 6

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 164

01/27/2015

Company Report

Pages: 7

Expanding Horizons; New $12 Price Target; Reiterate Buy

Provider: H.C. WAINWRIGHT & CO., INC.

Analyst: RAMAKANTH S

Price: 25.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 165

11/14/2014

Company Report

Pages: 9

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 166

11/13/2014

Daily Note

Pages: 6

Reports 3Q14 Results; Maintaining BUY Rating and 75 Cent PT

Provider: Merriman Curhan Ford & Co.

Analyst: D SILVA A

Price: 25.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 167

10/16/2014

Company Report

Pages: 5

Issues Update; Preliminary 3Q14 Product Sales Are Stronger Than Expected

Provider: Merriman Curhan Ford & Co.

Analyst: D SILVA A

Price: 10.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 168

10/14/2014

Company Report

Pages: 6

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 169

08/13/2014

Company Report

Pages: 6

Reports 2Q14 Results

Provider: Merriman Curhan Ford & Co.

Analyst: D SILVA A

Price: 25.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 170

08/13/2014

Company Report

Pages: 12

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 171

08/08/2014

Company Report

Pages: 6

2Q14 Earnings Preview

Provider: Merriman Curhan Ford & Co.

Analyst: D SILVA A

Price: 25.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 172

07/21/2014

Daily Note

Pages: 5

Positive Cardiac Surgery Data From An Investigator Initiated Study

Provider: Merriman Curhan Ford & Co.

Analyst: D SILVA A

Price: 10.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 173

06/19/2014

Company Report

Pages: 14

CytoSorbents, Reduced Inflammation Should Result in Share Appreciation; Initiating Coverage With a BUY

Provider: Merriman Curhan Ford & Co.

Analyst: D SILVA A

Price: 50.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 174

05/16/2014

Company Report

Pages: 11

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 175

04/03/2014

Company Report

Pages: 10

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 176

01/17/2014

Company Report

Pages: 5

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 177

11/08/2013

Company Report

Pages: 9

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 178

08/26/2013

Company Report

Pages: 6

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 179

08/14/2013

Company Report

Pages: 7

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 180

05/17/2013

Company Report

Pages: 7

Price: 24.95